The metabolic syndrome
Abstract The “metabolic syndrome”(MetS) is a clustering of components that reflect
overnutrition, sedentary lifestyles, and resultant excess adiposity. The MetS includes the …
overnutrition, sedentary lifestyles, and resultant excess adiposity. The MetS includes the …
Adipokines and insulin resistance
K Rabe, M Lehrke, KG Parhofer, UC Broedl - Molecular medicine, 2008 - Springer
Obesity is associated with an array of health problems in adult and pediatric populations.
Understanding the pathogenesis of obesity and its metabolic sequelae has advanced …
Understanding the pathogenesis of obesity and its metabolic sequelae has advanced …
[HTML][HTML] Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in
the liver of a patient with no history of alcohol abuse or other causes for secondary hepatic …
the liver of a patient with no history of alcohol abuse or other causes for secondary hepatic …
Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis
SG Spiroglou, CG Kostopoulos, JN Varakis… - … of atherosclerosis and …, 2010 - jstage.jst.go.jp
Aim: Adipokines are protein products of adipose tissue with paracrine and endocrine
actions, which have been implicated in the pathogenesis of cardiovascular disease. Locally …
actions, which have been implicated in the pathogenesis of cardiovascular disease. Locally …
Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
T Romacho, I Valencia, M Ramos-González… - Scientific reports, 2020 - nature.com
Abstract Visfatin/extracellular-nicotinamide-phosphoribosyltranferase-(eNampt) is a
multifaceted adipokine enhanced in type-2-diabetes and obesity. Visfatin/eNampt cause in …
multifaceted adipokine enhanced in type-2-diabetes and obesity. Visfatin/eNampt cause in …
[Retracted] Association between Tumor Prognosis Marker Visfatin and Proinflammatory Cytokines in Hypertensive Patients
R Parimelazhagan, D Umapathy… - BioMed research …, 2021 - Wiley Online Library
Visfatin has been reported as a risk factor and a potential diagnostic marker in cancer. It is
an adipokine, secreted by visceral fat and associated with the pathogenesis of arterial …
an adipokine, secreted by visceral fat and associated with the pathogenesis of arterial …
Visfatin/Nampt: an adipokine with cardiovascular impact
T Romacho, CF Sánchez-Ferrer… - Mediators of …, 2013 - Wiley Online Library
Adipose tissue is acknowledged as an endocrine organ that releases bioactive factors
termed adipokines. Visfatin was initially identified as a novel adipokine with insulin‐mimetic …
termed adipokines. Visfatin was initially identified as a novel adipokine with insulin‐mimetic …
[HTML][HTML] Role of visfatin in obesity-induced insulin resistance
MMI Abdalla - World journal of clinical cases, 2022 - ncbi.nlm.nih.gov
The growing worldwide burden of insulin resistance (IR) emphasizes the importance of early
identification for improved management. Obesity, particularly visceral obesity, has been a …
identification for improved management. Obesity, particularly visceral obesity, has been a …
Adipokines as clinically relevant therapeutic targets in obesity
Adipokines provide an outstanding role in the comprehensive etiology of obesity and may
link adipose tissue dysfunction to further metabolic and cardiovascular complications …
link adipose tissue dysfunction to further metabolic and cardiovascular complications …
Reviews: adipocytokines in normal and complicated pregnancies
DD Briana, A Malamitsi-Puchner - Reproductive Sciences, 2009 - journals.sagepub.com
Human pregnancy is characterized by insulin resistance, traditionally attributed to the effects
of placental hormones. Normal pregnancy—induced insulin resistance is further enhanced …
of placental hormones. Normal pregnancy—induced insulin resistance is further enhanced …